OnKure Therapeutics (OKUR) Shares Outstanding (2020 - 2026)

OnKure Therapeutics (OKUR) has 7 years of Shares Outstanding (Entity) data on file, last reported at $13.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 7.21% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (up 7.21% YoY) and the FY2025 annual result came in at $13.7 million, up 296.67% from the prior year.
• Shares Outstanding (Entity) was little changed at $13.7 million in Q1 2026, from $13.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $13.7 million in Q1 2026 to a low of $2.4 million in Q1 2022.
• A 5-year average of $6.0 million and a median of $3.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 1051.68% — and 2024, when it fell 1.29%.
• Tracing OKUR's Shares Outstanding (Entity) over 5 years: stood at $2.5 million in 2022, then soared by 35.31% to $3.3 million in 2023, then increased by 3.14% to $3.4 million in 2024, then jumped by 296.67% to $13.7 million in 2025, then advanced by 0.01% to $13.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $13.7 million (Q1 2026), $13.7 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.